In HR-positive tumors, all immune cell infiltrations were higher in the invasive component than in the DCIS component, and FOXP3+ TIL was significantly higher in DCIS-INV than in pure DCIS. The gene discussed is FOXP3; the disease is ductal breast carcinoma in situ.